Oligonucleotide Synthesis Market Size, Global Market Scope, Upcoming Trends And Regional Outlook To 2025
Oligonucleotide
Synthesis Market Synopsis
The chemical
synthesis of the nucleic acids with definite chemical structures is known as
oligonucleotide synthesis. Its ability to produce results regarding customized
nucleotides rapidly through inexpensive methods is making it choicest
preference for a lot of research laboratories that are spending heavily in
developing biotechnologies.
The major
factors identified as the positive drivers of the market are rising investment
by the government for the research and development of genomic technologies, high
rate of demand for innovation in the field of life science and medical
academics, rapid-paced advancements in the healthcare sector, and increasing
demand for oligonucleotide synthesis technologies by both public and
private research firms.
The Global
Oligonucleotide Synthesis Market is projected to attain a compound annual
growth rate of around 10.3% during the forecast period between 2016 and 2022.
Avail FREE Sample Here: https://www.marketresearchfuture.com/sample_request/2337
Moreover, an
increasing number of applications of oligonucleotide synthesis in genetic
testing, therapeutics, gene synthesis, diagnostic, research, library
preparation, drug target screening, and others is further strengthening the
growth of the global market.
Major Key Players Competitive Landscapes
The players
in the market are coming-up with new solutions and services and are
continuously striving for development. The global oligonucleotide synthesis
market includes a number of key players, including –
Bioautomation
Corporation (U.S.)
GE Healthcare
(U.S.)
Integrated
DNA Technologies Inc (U.S)
Thermo Fisher
Scientific Inc. (U.S.)
Nitto Denko
Avecia Inc. (Japan)
Agilent
Technologies Inc. (U.S.)
L.G.C
Biosearch Technologies (U.S.)
Sigma-Aldrich
Corporation (U.S.)
Eurogentec
S.A (Belgium)
Eurofins
Genomics (Germany)
and others.
Market Segmentation
The global
oligonucleotide synthesis market segmentation is done on the basis of application,
product type, and end-users.
By
application, the market includes drug target screening, library preparation,
genetic testing, therapeutics, diagnostic, gene synthesis, research, and
others. The Drug target screening segment holds the largest share due to the
massive traction it receives from the pharmaceutical sector.
By end-users,
the market includes diagnostic laboratories, academic research institutes, and
pharmaceutical & biotechnology companies. Diagnostic laboratories segment
is calculated to record massive growth during the forecast period.
By product
type, the market includes reagents, synthesized oligonucleotides, and
equipment. The synthesized oligonucleotides segment boasts an impressive hold
over the global market.
Regional Analysis
The
geographical segmentation of the global oligonucleotide synthesis market covers
regions like Asia Pacific, Europe, North America, and the Middle East &
Africa (MEA).
Browse
Complete Premium Research details along with the TOC at: https://www.marketresearchfuture.com/reports/oligonucleotide-synthesis-market-2337
North America
leads the global charts with the highest share of the market. The regional
market is further expected to expand in the forthcoming years primarily due to
the constant search for better treatments. The robust and developed healthcare
structure and infrastructure of the research centers are indicative of the
constant efforts put-in to fulfill this need. The region is also driven by the
prevalence of chronic diseases like cancer and diabetes. Additionally, both
government and private investors are providing constant funding to
bring-forward innovation and development into the sector. This is also steering
the market growth of North America forward.
Europe holds
the second spot in the global market standings of oligonucleotide synthesis. The
regional market herein is driven by the same intent as that of North America and
is amply backed by government initiatives and research centers. The regional
market is aided with investments from various pharmaceutical companies in order
to understand the gene sequencing to develop improved drugs. The Asia Pacific
region is anticipated to significantly rise in the forthcoming years as many of
the leading players in the global market see the region as a massive scope of
investment opportunity. Herein, infrastructural benefits and the pricing of
resources are some of the most important factors that are stimulating a
positive growth of the market.
In order to stay updated with technology and work process of the
industry, MRFR often plans & conducts meet with the industry experts and
industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment